T Cells and Antigen-Specificity | 2nd Heidelberg Symposium

Applications in Infectious Disease and Immuno-Oncology

In April, Immudex will be hosting a symposium in Heidelberg where researchers from the area will give presentations about their research in the area of antigen-specific immune monitoring of T cells.

This event is free to attend but the number of places is limited so please register to secure your seat.

Date: 17 April 2024

Time: 10:00 – 15:00

Location:  Frauenbad Heidelberg, Berghelmer Str. 45, 69115 Heidelberg, Germany



Morning coffee/tea


Dr. Michael Delacher, Group Leader, Institute of Immunology Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Main

T cells and their role in tissue remodeling and regeneration


Dr. Isabel PoschkeHead of Immune Monitoring Unit. German Cancer Research Center (DKFZ), Heidelberg

Next-generation immune monitoring in immuno-oncology trials – repertoires, receptors, reactivities


Dr. Ignazio Caruana, Group Leader, University Hospital of Würzburg



Dr. Jonas Becker, Division of Immunotherapy and Immunoprevention (Prof. Angelika Riemer's Lab), DKFZ

The importance of being presented: T cell epitope identification by mass spectrometry-based immunopeptidomics


Lunch & Get Together

Dr. Kilian Schober, Group Leader, Erlangen University Hospital

Identification and characterization of human antigen-specific T cells


Dr. Thomas Holberg Blicher, Senior Scientist, Immudex

TCR Discovery and Validation


Dr. Alena Reguzova, Senior Scientist, Prof. Ralf Amann’s Lab, University of Tübingen

Advancing next-generation multi-antigen vaccine concepts with a novel Orf virus-based platform


Dr. Mohammad Salem, Senior Pharma Business & Solution Manager, Immudex

Artificial Antigen-Presenting Scaffolds: A Tailored Approach for T-Cell Stimulation and Expansion



Meet the Team

Mohammad Salem, PhD

Senior Pharma Business & Solution Manager

Thomas Holberg Blicher, PhD

Senior Scientist